Bamberg M - Search Results

1

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: bamberg m. J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. doi: 10.1007/s00432-005-0681-0. Epub 2005 May 11. J Cancer Res Clin Oncol. 2005. PMID: 15887028 Review.

2

Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Ganswindt U, Paulsen F, Corvin S, Eichhorn K, Glocker S, Hundt I, Birkner M, Alber M, Anastasiadis A, Stenzl A, Bares R, Budach W, Bamberg M, Belka C. Ganswindt U, et al. Among authors: bamberg m. BMC Cancer. 2005 Jul 28;5:91. doi: 10.1186/1471-2407-5-91. BMC Cancer. 2005. PMID: 16048656 Free PMC article.

3

Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.

Ganswindt U, Paulsen F, Corvin S, Hundt I, Alber M, Frey B, Stenzl A, Bares R, Bamberg M, Belka C. Ganswindt U, et al. Among authors: bamberg m. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):347-55. doi: 10.1016/j.ijrobp.2006.08.082. Int J Radiat Oncol Biol Phys. 2007. PMID: 17236960

4

Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?

Ganswindt U, Stenzl A, Bamberg M, Belka C. Ganswindt U, et al. Among authors: bamberg m. Eur Urol. 2008 Sep;54(3):528-42. doi: 10.1016/j.eururo.2008.06.059. Epub 2008 Jun 23. Eur Urol. 2008. PMID: 18602742 Review.

5

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.

Eckert F, Alloussi S, Paulsen F, Bamberg M, Zips D, Spillner P, Gani C, Kramer U, Thorwarth D, Schilling D, Müller AC. Eckert F, et al. Among authors: bamberg m. BMC Cancer. 2013 Jan 22;13:27. doi: 10.1186/1471-2407-13-27. BMC Cancer. 2013. PMID: 23336502 Free PMC article. Clinical Trial.

6

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study.

Ganswindt U, Budach W, Jendrossek V, Becker G, Bamberg M, Belka C. Ganswindt U, et al. Among authors: bamberg m. Radiat Oncol. 2006 Apr 10;1:9. doi: 10.1186/1748-717X-1-9. Radiat Oncol. 2006. PMID: 16722607 Free PMC article. Clinical Trial.

7

Toxicity and outcome of pelvic IMRT for node-positive prostate cancer.

Müller AC, Lütjens J, Alber M, Eckert F, Bamberg M, Schilling D, Belka C, Ganswindt U. Müller AC, et al. Among authors: bamberg m. Strahlenther Onkol. 2012 Nov;188(11):982-9. doi: 10.1007/s00066-012-0169-1. Epub 2012 Oct 11. Strahlenther Onkol. 2012. PMID: 23053142

8

Risk of second malignancies after prostate irradiation?

Müller AC, Ganswindt U, Bamberg M, Belka C. Müller AC, et al. Among authors: bamberg m. Strahlenther Onkol. 2007 Nov;183(11):605-9. doi: 10.1007/s00066-007-1786-y. Strahlenther Onkol. 2007. PMID: 17960335 Review.

9

Hypofractionated reirradiation for recurrent malignant glioma.

Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, Bamberg M, Belka C. Henke G, et al. Among authors: bamberg m. Strahlenther Onkol. 2009 Feb;185(2):113-9. doi: 10.1007/s00066-009-1969-9. Epub 2009 Feb 25. Strahlenther Onkol. 2009. PMID: 19240998

10

Impact of radiotherapy, chemotherapy and surgery in multimodal treatment of locally advanced esophageal cancer.

Berger B, Stahlberg K, Lemminger A, Bleif M, Belka C, Bamberg M. Berger B, et al. Among authors: bamberg m. Oncology. 2011;81(5-6):387-94. doi: 10.1159/000335263. Epub 2012 Jan 20. Oncology. 2011. PMID: 22269965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page